Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit
Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...To view the full article, register now.
Already a subscriber? Click here to view full article